Dalzanemdor

Overview of the drug Dalzanemdor

Dalzanemdor
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Dalzanemdor is a pharmaceutical drug that acts as a selective serotonin reuptake inhibitor (SSRI). It is primarily used in the treatment of major depressive disorder and other anxiety disorders.

Mechanism of Action

Dalzanemdor functions by inhibiting the reuptake of serotonin in the synaptic cleft, thereby increasing the availability of serotonin in the central nervous system. This action is believed to contribute to its antidepressant and anxiolytic effects.

Pharmacokinetics

Dalzanemdor is administered orally and is well absorbed from the gastrointestinal tract. It undergoes extensive hepatic metabolism, primarily through the cytochrome P450 enzyme system. The drug has a half-life of approximately 24 hours, allowing for once-daily dosing.

Clinical Uses

Dalzanemdor is indicated for the treatment of:

• Major depressive disorder
• Generalized anxiety disorder
• Obsessive-compulsive disorder
• Panic disorder

Side Effects

Common side effects of Dalzanemdor include:

• Nausea
• Headache
• Insomnia
• Sexual dysfunction

Less common but serious side effects may include:

• Serotonin syndrome
• Suicidal thoughts in young adults

Contraindications

Dalzanemdor is contraindicated in patients with known hypersensitivity to the drug or any of its components. It should not be used in conjunction with monoamine oxidase inhibitors (MAOIs) due to the risk of serotonin syndrome.

Related pages

• Selective serotonin reuptake inhibitor
• Major depressive disorder
• Anxiety disorder